Assistant Professor of Strategy
Jennifer Kao’s research interests lie in the economics of innovation and science, firm strategy and health care. Her work seeks to understand how information and regulation shape firms’ incentives to innovate. A recent project explores how publicly available scientific information shapes the rate, direction and profitability of innovation in the pharmaceutical industry. Other projects examine how drug approval regulation shapes firms’ market entry strategies.
U.S. efforts to encourage transparency widely ignored by companies
Hint: Not the pharmaceutical companies that developed them
Dedicated FDA staff guide companies during design of clinical trials
Pharma companies less likely to disclose critical drug information than public institutions
Following Medicare reimbursement rate changes, research actually increased
Pharmaceutical companies are better able to identify promising new applications for existing drugs